PL429246A1 - Analgesic and anti-inflammatory pharmaceutical composition for use in the prevention of fever and/or pain, in particular for use in mouth and throat inflammation - Google Patents
Analgesic and anti-inflammatory pharmaceutical composition for use in the prevention of fever and/or pain, in particular for use in mouth and throat inflammationInfo
- Publication number
- PL429246A1 PL429246A1 PL429246A PL42924619A PL429246A1 PL 429246 A1 PL429246 A1 PL 429246A1 PL 429246 A PL429246 A PL 429246A PL 42924619 A PL42924619 A PL 42924619A PL 429246 A1 PL429246 A1 PL 429246A1
- Authority
- PL
- Poland
- Prior art keywords
- analgesic
- fever
- pharmaceutical composition
- pain
- prevention
- Prior art date
Links
- 206010037660 Pyrexia Diseases 0.000 title abstract 2
- 230000000202 analgesic effect Effects 0.000 title abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 201000007100 Pharyngitis Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229960001680 ibuprofen Drugs 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 abstract 1
- 210000003300 oropharynx Anatomy 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000811 xylitol Substances 0.000 abstract 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 abstract 1
- 229960002675 xylitol Drugs 0.000 abstract 1
- 235000010447 xylitol Nutrition 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Zgłoszenie dotyczy przeciwbólowo - przeciwzapalnej kompozycji farmaceutycznej do stosowania podczas gorączki i/lub w stanach zapalnych jamy ustnej i gardła, w postaci tabletki pudrowej, zawierającej ibuprofen lub jego dopuszczalną farmaceutycznie sól oraz co najmniej jedną farmaceutycznie dopuszczalną zaróbkę, charakteryzującej się tym, że zawiera od 5 mg do 400 mg substancji czynnej przeciwbólowej i przeciwzapalnej oraz ksylitol w ilości 30 - 90% wagowych.The application relates to an analgesic-anti-inflammatory pharmaceutical composition for use in the treatment of fever and / or inflammation of the oropharynx, in the form of a powder tablet containing ibuprofen or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable excipient, characterized in that it contains from 5 mg to 400 mg of analgesic and anti-inflammatory active ingredient and xylitol in an amount of 30-90% by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL429246A PL237530B1 (en) | 2019-03-13 | 2019-03-13 | Analgesic and anti-inflammatory pharmaceutical composition for use in the prevention of fever and/or pain, in particular for use in mouth and throat inflammation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL429246A PL237530B1 (en) | 2019-03-13 | 2019-03-13 | Analgesic and anti-inflammatory pharmaceutical composition for use in the prevention of fever and/or pain, in particular for use in mouth and throat inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL429246A1 true PL429246A1 (en) | 2020-09-21 |
| PL237530B1 PL237530B1 (en) | 2021-04-19 |
Family
ID=72561437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL429246A PL237530B1 (en) | 2019-03-13 | 2019-03-13 | Analgesic and anti-inflammatory pharmaceutical composition for use in the prevention of fever and/or pain, in particular for use in mouth and throat inflammation |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL237530B1 (en) |
-
2019
- 2019-03-13 PL PL429246A patent/PL237530B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL237530B1 (en) | 2021-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021066744A5 (en) | Composition containing bupropion and dextromethorphan | |
| DE60032749D1 (en) | STABILIZED PHARMACEUTICAL COMPOSITION CONTAINING AN NON-TEROID INFUSE-INFLAMMATIVE AGGREGATE AND PROSTAGLANDIN | |
| EA200700049A1 (en) | PREPARATIVE FORMS OF ORAL MEDICINAL FORMS OF MEMANTINE WITH MODIFIED SURVIVAL | |
| WO2005065069A3 (en) | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease | |
| HRP20150644T1 (en) | A METHOD FOR ATRIAL FIBRATION TREATMENT | |
| HRP20220902T3 (en) | Compositions and uses for treating multiple sclerosis | |
| WO2010103544A3 (en) | A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants | |
| JP2015038135A5 (en) | ||
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| Lee et al. | Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial | |
| WO2008142572A3 (en) | Controlled release tablet formulation containing magnesium aluminometasilicate | |
| EA202090029A1 (en) | SOLID CARIPRAZINE COMPOSITION FOR ORAL INTRODUCTION | |
| WO2008023016A3 (en) | Galenic formulations of aliskiren | |
| ATE298324T1 (en) | DEUTERATED 3-PIPERIDINOPROPIOPHENONE AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS | |
| AR046036A1 (en) | RISEDRONATE COMPOSITIONS AND METHODS FOR USE | |
| BRPI0412364A (en) | solid pharmaceutical composition comprising amisulpride | |
| HRP20240812T1 (en) | Dosage forms and therapeutic uses l-4-chlorokynurenine | |
| JP2016505050A5 (en) | ||
| HRP20251043T1 (en) | A NEW ORAL PHARMACEUTICAL PREPARATION AND DOSAGE REGIME FOR THE THERAPY OF PROGRESSIVE FIBROSITISING INTERSTITIAL LUNG DISEASES | |
| HRP20211661T1 (en) | Igmesine for use in the treatment of alzheimer's disease | |
| CO2025007025A2 (en) | Oral compactable formulations of ibutamoren | |
| MX384760B (en) | A synergic pharmaceutical combination of the active etianomer s-ketorolaco and gabapentin for the treatment of neuropathic pain | |
| NZ594669A (en) | Oral composition of Vorinostat | |
| WO2020018048A3 (en) | An immediate release pharmaceutical composition of anti-inflammatory drugs, famotidine and a carbonate | |
| WO2019203759A3 (en) | Combinations of etodolac with h2 receptor antagonists for the treatment of pain and inflammation. |